This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lu, J.
Right arrow Articles by Ito, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lu, J.
Right arrow Articles by Ito, Y.

 Previous Article  |  Next Article 

Mol. Cell. Biol., 03 1995, 1651-1661, Vol 15, No. 3
Copyright © 1995, American Society for Microbiology

Subcellular localization of the alpha and beta subunits of the acute myeloid leukemia-linked transcription factor PEBP2/CBF

J Lu, M Maruyama, M Satake, SC Bae, E Ogawa, H Kagoshima, K Shigesada and Y Ito
Department of Viral Oncology, Kyoto University, Japan.

Each of the two human genes encoding the alpha and beta subunits of a heterodimeric transcription factor, PEBP2, has been found at the breakpoints of two characteristic chromosome translocations associated with acute myeloid leukemia, suggesting that they are candidate proto- oncogenes. Polyclonal antibodies against the alpha and beta subunits of PEBP2 were raised in rabbits and hamsters. Immunofluorescence labeling of NIH 3T3 cells transfected with PEBP2 alpha and -beta cDNAs revealed that the full-size alpha A1 and alpha B1 proteins, the products of two related but distinct genes, are located in the nucleus, while the beta subunit is localized to the cytoplasm. Deletion analysis demonstrated that there are two regions in alpha A1 responsible for nuclear accumulation of the protein: one mapped in the region between amino acids 221 and 513, and the other mapped in the Runt domain (amino acids 94 to 221) harboring the DNA-binding and the heterodimerizing activities. When the full-size alpha A1 and beta proteins are coexpressed in a single cell, the former is present in the nucleus and the latter still remains in the cytoplasm. However, the N- or C- terminally truncated alpha A1 proteins devoid of the region upstream or downstream of the Runt domain colocalized with the beta protein in the nucleus. In these cases, the beta protein appeared to be translocated into the nucleus passively by binding to alpha A1. The chimeric protein containing the beta protein at the N-terminal region generated as a result of the inversion of chromosome 16 colocalized with alpha A1 to the nucleus more readily than the normal beta protein. The implications of these results in relation to leukemogenesis are discussed.


This article has been cited by other articles:

  • Wee, H.-J., Voon, D. C.-C., Bae, S.-C., Ito, Y. (2008). PEBP2-{beta}/CBF-{beta}-dependent phosphorylation of RUNX1 and p300 by HIPK2: implications for leukemogenesis. Blood 112: 3777-3787 [Abstract] [Full Text]  
  • Ogawa, S., Satake, M., Ikuta, K. (2008). Physical and Functional Interactions between STAT5 and Runx Transcription Factors. J Biochem 143: 695-709 [Abstract] [Full Text]  
  • Xuan, D., Li, S., Zhang, X., Hu, F., Lin, L., Wang, C., Zhang, J. (2008). Mutations in the RUNX2 Gene in Chinese Patients with Cleidocranial Dysplasia. Annals of Clinical & Laboratory Science 38: 15-24 [Abstract] [Full Text]  
  • Ito, K., Liu, Q., Salto-Tellez, M., Yano, T., Tada, K., Ida, H., Huang, C., Shah, N., Inoue, M., Rajnakova, A., Hiong, K. C., Peh, B. K., Han, H. C., Ito, T., Teh, M., Yeoh, K. G., Ito, Y. (2005). RUNX3, A Novel Tumor Suppressor, Is Frequently Inactivated in Gastric Cancer by Protein Mislocalization. Cancer Res. 65: 7743-7750 [Abstract] [Full Text]  
  • Liu, H., Holm, M., Xie, X.-Q., Wolf-Watz, M., Grundstrom, T. (2004). AML1/Runx1 Recruits Calcineurin to Regulate Granulocyte Macrophage Colony-stimulating Factor by Ets1 Activation. J. Biol. Chem. 279: 29398-29408 [Abstract] [Full Text]  
  • Huang, G., Shigesada, K., Wee, H.-J., Liu, P. P., Osato, M., Ito, Y. (2004). Molecular basis for a dominant inactivation of RUNX1/AML1 by the leukemogenic inversion 16 chimera. Blood 103: 3200-3207 [Abstract] [Full Text]  
  • Bernardin-Fried, F., Kummalue, T., Leijen, S., Collector, M. I., Ravid, K., Friedman, A. D. (2004). AML1/RUNX1 Increases During G1 to S Cell Cycle Progression Independent of Cytokine-dependent Phosphorylation and Induces Cyclin D3 Gene Expression. J. Biol. Chem. 279: 15678-15687 [Abstract] [Full Text]  
  • Telfer, J. C., Hedblom, E. E., Anderson, M. K., Laurent, M. N., Rothenberg, E. V. (2004). Localization of the Domains in Runx Transcription Factors Required for the Repression of CD4 in Thymocytes. J. Immunol. 172: 4359-4370 [Abstract] [Full Text]  
  • Kummalue, T., Lou, J., Friedman, A. D. (2002). Multimerization via Its Myosin Domain Facilitates Nuclear Localization and Inhibition of Core Binding Factor (CBF) Activities by the CBF{beta}-Smooth Muscle Myosin Heavy Chain Myeloid Leukemia Oncoprotein. Mol. Cell. Biol. 22: 8278-8291 [Abstract] [Full Text]  
  • Michaud, J., Wu, F., Osato, M., Cottles, G. M., Yanagida, M., Asou, N., Shigesada, K., Ito, Y., Benson, K. F., Raskind, W. H., Rossier, C., Antonarakis, S. E., Israels, S., McNicol, A., Weiss, H., Horwitz, M., Scott, H. S. (2002). In vitro analyses of known and novel RUNX1/AML1 mutations in dominant familial platelet disorder with predisposition to acute myelogenous leukemia: implications for mechanisms of pathogenesis. Blood 99: 1364-1372 [Abstract] [Full Text]  
  • Zhang, Y.-W., Yasui, N., Ito, K., Huang, G., Fujii, M., Hanai, J.-i., Nogami, H., Ochi, T., Miyazono, K., Ito, Y. (2000). A RUNX2/PEBP2alpha A/CBFA1 mutation displaying impaired transactivation and Smad interaction in cleidocranial dysplasia. Proc. Natl. Acad. Sci. USA 10.1073/pnas.180309597v1 [Abstract] [Full Text]  
  • Enomoto, H., Enomoto-Iwamoto, M., Iwamoto, M., Nomura, S., Himeno, M., Kitamura, Y., Kishimoto, T., Komori, T. (2000). Cbfa1 Is a Positive Regulatory Factor in Chondrocyte Maturation. J. Biol. Chem. 275: 8695-8702 [Abstract] [Full Text]  
  • Javed, A, Guo, B, Hiebert, S, Choi, J., Green, J, Zhao, S., Osborne, M., Stifani, S, Stein, J., Lian, J., van Wijnen, A., Stein, G. (2000). Groucho/TLE/R-esp proteins associate with the nuclear matrix and repress RUNX (CBF(alpha)/AML/PEBP2(alpha)) dependent activation of tissue-specific gene transcription. J. Cell Sci. 113: 2221-2231 [Abstract]  
  • Gu, T.-L., Goetz, T. L., Graves, B. J., Speck, N. A. (2000). Auto-Inhibition and Partner Proteins, Core-Binding Factor beta (CBFbeta ) and Ets-1, Modulate DNA Binding by CBFalpha 2 (AML1). Mol. Cell. Biol. 20: 91-103 [Abstract] [Full Text]  
  • McNeil, S., Zeng, C., Harrington, K. S., Hiebert, S., Lian, J. B., Stein, J. L., van Wijnen, A. J., Stein, G. S. (1999). The t(8;21) chromosomal translocation in acute myelogenous leukemia modifies intranuclear targeting of the AML1/CBFalpha 2 transcription factor. Proc. Natl. Acad. Sci. USA 96: 14882-14887 [Abstract] [Full Text]  
  • Le, X.-F., Groner, Y., Kornblau, S. M., Gu, Y., Hittelman, W. N., Levanon, D., Mehta, K., Arlinghaus, R. B., Chang, K.-S. (1999). Regulation of AML2/CBFA3 in Hematopoietic Cells through the Retinoic Acid Receptor alpha -Dependent Signaling Pathway. J. Biol. Chem. 274: 21651-21658 [Abstract] [Full Text]  
  • Jimenez, M. J. G., Balbin, M., Lopez, J. M., Alvarez, J., Komori, T., Lopez-Otin, C. (1999). Collagenase 3 Is a Target of Cbfa1, a Transcription Factor of the runt Gene Family Involved in Bone Formation. Mol. Cell. Biol. 19: 4431-4442 [Abstract] [Full Text]  
  • Osaka, M., Rowley, J. D., Zeleznik-Le, N. J. (1999). MSF (MLL septin-like fusion), a fusion partner gene of MLL, in a therapy-related acute myeloid leukemia with a t(11;17)(q23;q25). Proc. Natl. Acad. Sci. USA 96: 6428-6433 [Abstract] [Full Text]  
  • Osato, M., Asou, N., Abdalla, E., Hoshino, K., Yamasaki, H., Okubo, T., Suzushima, H., Takatsuki, K., Kanno, T., Shigesada, K., Ito, Y. (1999). Biallelic and Heterozygous Point Mutations in the Runt Domain of the AML1/PEBP2alpha B Gene Associated With Myeloblastic Leukemias. Blood 93: 1817-1824 [Abstract] [Full Text]  
  • Adya, N., Stacy, T., Speck, N. A., Liu, P. P. (1998). The Leukemic Protein Core Binding Factor beta  (CBFbeta )-Smooth-Muscle Myosin Heavy Chain Sequesters CBFalpha 2 into Cytoskeletal Filaments and Aggregates. Mol. Cell. Biol. 18: 7432-7443 [Abstract] [Full Text]  
  • Cao, W., Adya, N., Britos-Bray, M., Liu, P. P., Friedman, A. D. (1998). The Core Binding Factor (CBF) alpha  Interaction Domain and the Smooth Muscle Myosin Heavy Chain (SMMHC) Segment of CBFbeta -SMMHC Are Both Required to Slow Cell Proliferation. J. Biol. Chem. 273: 31534-31540 [Abstract] [Full Text]  
  • Kogan, S. C., Lagasse, E., Atwater, S., Bae, S.-c., Weissman, I., Ito, Y., Bishop, J. M. (1998). The PEBP2beta MYH11 fusion created by Inv(16)(p13;q22) in myeloid leukemia impairs neutrophil maturation and contributes to granulocytic dysplasia. Proc. Natl. Acad. Sci. USA 95: 11863-11868 [Abstract] [Full Text]  
  • Thirunavukkarasu, K., Mahajan, M., McLarren, K. W., Stifani, S., Karsenty, G. (1998). Two Domains Unique to Osteoblast-Specific Transcription Factor Osf2/Cbfa1 Contribute to Its Transactivation Function and Its Inability To Heterodimerize with Cbfbeta. Mol. Cell. Biol. 18: 4197-4208 [Abstract] [Full Text]  
  • Kanno, Y., Kanno, T., Sakakura, C., Bae, S.-C., Ito, Y. (1998). Cytoplasmic Sequestration of the Polyomavirus Enhancer Binding Protein 2 (PEBP2)/Core Binding Factor alpha  (CBFalpha ) Subunit by the Leukemia-Related PEBP2/CBFbeta -SMMHC Fusion Protein Inhibits PEBP2/CBF-Mediated Transactivation. Mol. Cell. Biol. 18: 4252-4261 [Abstract] [Full Text]  
  • Kanno, T., Kanno, Y., Chen, L.-F., Ogawa, E., Kim, W.-Y., Ito, Y. (1998). Intrinsic Transcriptional Activation-Inhibition Domains of the Polyomavirus Enhancer Binding Protein 2/Core Binding Factor alpha  Subunit Revealed in the Presence of the beta  Subunit. Mol. Cell. Biol. 18: 2444-2454 [Abstract] [Full Text]  
  • Tanaka, K., Tanaka, T., Kurokawa, M., Imai, Y., Ogawa, S., Mitani, K., Yazaki, Y., Hirai, H. (1998). The AML1/ETO(MTG8) and AML1/Evi-1 Leukemia-Associated Chimeric Oncoproteins Accumulate PEBP2beta (CBFbeta ) in the Nucleus More Efficiently Than Wild-Type AML1. Blood 91: 1688-1699 [Abstract] [Full Text]  
  • Ahn, M.-Y., Huang, G., Bae, S.-C., Wee, H.-J., Kim, W.-Y., Ito, Y. (1998). Negative regulation of granulocytic differentiation in the myeloid precursor cell line 32Dcl3 by ear-2, a mammalian homolog of Drosophila seven-up, and a chimeric leukemogenic gene, AML1/ETO(MTG8). Proc. Natl. Acad. Sci. USA 95: 1812-1817 [Abstract] [Full Text]  
  • Babichuk, C. K., Bleackley, R. C. (1997). Mutational Analysis of the Murine Granzyme B Gene Promoter in Primary T Cells and a T Cell Clone. J. Biol. Chem. 272: 18564-18571 [Abstract] [Full Text]  
  • Zeng, C., van Wijnen, A. J., Stein, J. L., Meyers, S., Sun, W., Shopland, L., Lawrence, J. B., Penman, S., Lian, J. B., Stein, G. S., Hiebert, S. W. (1997). Identification of a nuclear matrix targeting signal in the leukemia and bone-related AML/CBF-alpha transcription factors. Proc. Natl. Acad. Sci. USA 94: 6746-6751 [Abstract] [Full Text]  
  • Akamatsu, Y., Ohno, T., Hirota, K., Kagoshima, H., Yodoi, J., Shigesada, K. (1997). Redox Regulation of the DNA Binding Activity in Transcription Factor PEBP2. THE ROLES OF TWO CONSERVED CYSTEINE RESIDUES. J. Biol. Chem. 272: 14497-14500 [Abstract] [Full Text]  
  • Niki, M., Okada, H., Takano, H., Kuno, J., Tani, K., Hibino, H., Asano, S., Ito, Y., Satake, M., Noda, T. (1997). Hematopoiesis in the fetal liver is impaired by targeted mutagenesis of a gene encoding a non-DNA binding subunit of the transcription factor, polyomavirus enhancer binding protein 2/core binding factor. Proc. Natl. Acad. Sci. USA 94: 5697-5702 [Abstract] [Full Text]  
  • Corsetti, M. T., Calabi, F. (1997). Lineage- and Stage-Specific Expression of Runt Box Polypeptides in Primitive and Definitive Hematopoiesis. Blood 89: 2359-2368 [Abstract] [Full Text]  
  • Kagoshima, H., Akamatsu, Y., Ito, Y., Shigesada, K. (1996). Functional Dissection of the alpha and beta Subunits of Transcription Factor PEBP2 and the Redox Susceptibility of Its DNA Binding Activity. J. Biol. Chem. 271: 33074-33082 [Abstract] [Full Text]  
  • Babichuk, C. K., Duggan, B. L., Bleackley, R. C. (1996). In Vivo Regulation of Murine Granzyme B Gene Transcription in Activated Primary T Cells. J. Biol. Chem. 271: 16485-16493 [Abstract] [Full Text]  
  • Kurokawa, M., Tanaka, T., Tanaka, K., Hirano, N., Ogawa, S., Mitani, K., Yazaki, Y., Hirai, H. (1996). A Conserved Cysteine Residue in the runt Homology Domain of AML1 Is Required for the DNA Binding Ability and the Transforming Activity on Fibroblasts. J. Biol. Chem. 271: 16870-16876 [Abstract] [Full Text]  
  • Armesilla, A. L., Calvo, D., Vega, M. A. (1996). Structural and Functional Characterization of the Human CD36 Gene Promoter. J. Biol. Chem. 271: 7781-7787 [Abstract] [Full Text]  
  • McCarthy, T. L., Ji, C., Chen, Y., Kim, K. K., Imagawa, M., Ito, Y., Centrella, M. (2000). Runt Domain Factor (Runx)-dependent Effects on CCAAT/ Enhancer-binding Protein delta Expression and Activity in Osteoblasts. J. Biol. Chem. 275: 21746-21753 [Abstract] [Full Text]  
  • Choi, J.-Y., Pratap, J., Javed, A., Zaidi, S. K., Xing, L., Balint, E., Dalamangas, S., Boyce, B., van Wijnen, A. J., Lian, J. B., Stein, J. L., Jones, S. N., Stein, G. S. (2001). Subnuclear targeting of Runx/Cbfa/AML factors is essential for tissue-specific differentiation during embryonic development. Proc. Natl. Acad. Sci. USA 98: 8650-8655 [Abstract] [Full Text]  
  • Zhang, Y.-W., Yasui, N., Ito, K., Huang, G., Fujii, M., Hanai, J.-i., Nogami, H., Ochi, T., Miyazono, K., Ito, Y. (2000). A RUNX2/PEBP2alpha A/CBFA1 mutation displaying impaired transactivation and Smad interaction in cleidocranial dysplasia. Proc. Natl. Acad. Sci. USA 97: 10549-10554 [Abstract] [Full Text]